Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Genetic Testing. Found 18 abstracts

Bradbury AR, Patrick-Miller LJ, Egleston BL, DiGiovanni L, Brower J, Harris D, Stevens EM, Maxwell KN, Kulkarni A, Chavez T, Brandt A, Long JM, Powers J, Stopfer JE, Nathanson KL, Domchek SM. Patient feedback and early outcome data with a novel tiered-binned model for multiplex breast cancer susceptibility testing. Genet Med. 2016 Jan;18(1):25-33.
Siminoff LA, Traino HM, Mosavel M, Barker L, Gudger G, Undale A. Family decision maker perspectives on the return of genetic results in biobanking research. Genet Med. 2016 Jan;18(1):82-8.   PMCID: PMC4600004
Bradbury AR, Patrick-Miller L, Long J, Powers J, Stopfer J, Forman A, Rybak C, Mattie K, Brandt A, Chambers R, Chung WK, Churpek J, Daly MB, Digiovanni L, Farengo-Clark D, Fetzer D, Ganschow P, Grana G, Gulden C, Hall M, Kohler L, Maxwell K, Merrill S, Montgomery S, Mueller R, Nielsen S, Olopade O, Rainey K, Seelaus C, Nathanson KL, Domchek SM. Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility. Genetics in Medicine. 2015 Jun;17(6):485-92.   PMCID: 4983405
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw. 2015 May;13(5):515-24.
Shih J, Bashir B, Gustafson KS, Andrake M, Dunbrack RL, Goldstein LJ, Boumber Y. Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary. J Natl Compr Canc Netw. 2015 Aug;13(8):947-52.   PMCID: 4763101
Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R. Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38.
Hall MJ. Conflicted confidence: academic oncologists' views on multiplex pharmacogenomic testing. J Clin Oncol. 2014 May;32(13):1290-2.   PMCID: Comment
Hall MJ, Herda MM, Handorf EA, Rybak CC, Keleher CA, Siemon M, Daly MB. Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility study. Genet Med. 2014 Nov;16(11):854-61.   PMCID: PMC4216634
Weinberg DS, Myers RE, Keenan E, Ruth K, Sifri R, Ziring B, Ross E, Manne SL. Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. Annals of internal medicine. 2014 Oct 21;161(8):537-45.   PMCID: 4412019
Adonizio C, Gazzillo M, Knezetic J, Snyder C, Lynch HT, Rybak C, Hall MJ, Lowstuter K, Eggington J, Morris GJ. Thirty-nine-year-old with familial colon cancer, and variant of undetermined significance in MSH6. Semin Oncol. 2012 Apr;39(2):125-31.   PMCID: not NIH funded - case report
Roussi P, Sherman K, Miller S, Hurley K, Daly M, Godwin A, Buzaglo J, Wen K. Identification of cognitive profiles among women considering BRCA1/2 testing through the utilisation of cluster analytic techniques. Psychology & Health. 2011 Jan;26(10):1327-43.   PMCID: PMC3197930
Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H, Kaklamani V, Kohlmann W, Kurian A, Litton J, Marcom PK, Nussbaum R, Offit K, Pal T, Pasche B, Pilarski R, Reiser G, Shannon KM, Smith JR, Swisher E, Weitzel JN, National Comprehensive Cancer N. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010 May;8(5):562-94.   PMCID: not NIH funded
Roussi P, Sherman KA, Miller S, Buzaglo J, Daly M, Taylor A, Ross E, Godwin A. Enhanced counselling for women undergoing BRCA1/2 testing: Impact on knowledge and psychological distress-results from a randomised clinical trial. Psychol Health. 2010 Apr;25(4):401-15.   PMCID: Pmc2866521
Wang C, Miller SM. Psychological issues in genetic testing. [References]. In: Miller SM, Bowen DJ, Croyle RT, Rowland JH, editors. Handbook of cancer control and behavioral science: A resource for researchers, practitioners, and policymakers. Washington, DC: American Psychological Association; 2009. p. 303-21.
Sweed MF, Vig HS. Hereditary colorectal cancer syndromes. Start risk assessment in primary care. Adv Nurse Pract. 2007 Jul;15(7):49-52.
Wang C, Gonzalez R, Janz NK, Milliron KJ, Merajver SD. The role of cognitive appraisal and worry in BRCA1/2 testing decisions among a clinic population. Psychology & Health. 2007 Aug;22(6):719-36.
Miller SM, Roussi P, Daly MB, Buzaglo JS, Sherman K, Godwin AK, Balshem A, Atchison ME. Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors. Health education & behavior : the official publication of the Society for Public Health Education. 2005 Oct;32(5):654-67.
Roussi P, Miller SM. Genetic testing for breast and ovarian cancer: A review of psychological and behavioral outcomes. Hellenic Journal of Psychology. 2005 Aug;2(2):135.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Genetic Testing

Genetic Testing genetics Female Genetic Counseling diagnosis Genetic Predisposition to Disease Middle Aged Male methods Neoplasms Breast Neoplasms Decision Making Risk Assessment psychology Ovarian Neoplasms therapy BRCA2 Protein BRCA1 Protein Adult Lung Neoplasms Hereditary Nonpolyposis Colorectal Neoplasms Pedigree Comprehension Mutation ethics Early Detection of Cancer Informed Consent Colorectal Neoplasms Aged Multiple Hamartoma Syndrome X-Ray Computed Tomography Folic Acid Behavioral Assessment Health Attitudes Genetic Disorders Cognition Li-Fraumeni Syndrome Health Behavior Surveys and Questionnaires Treatment Outcomes Ovaries epidemiology Gene Amplification Self Regulation blood Genetic Variation surgery Tissue Donors genetic testing decisions 2-self-regulation-health Attitudes Health Knowledge-Practice Non-Small-Cell Lung Carcinoma Personal Health Records Attitude At Risk Populations Counseling Methylenetetrahydrofolate Reductase (NADPH2) DNA-Binding Proteins Treatment Outcome Feasibility Studies ErbB-2 Receptor Brain Neoplasms Adenomatous Polyposis Coli Colonic Neoplasms Genetic Polymorphism Biological Specimen Banks Thoracic Radiography Peutz-Jeghers Syndrome United States DNA Mismatch Repair Psychosocial Factors BRCA2 Genes worry cognitive appraisal-BRCA1 Antineoplastic Combined Chemotherapy Protocols Hereditary Neoplastic Syndromes BRCA1 Genes Breast Self-Examination Patient Access to Records Heterozygote Physicians Germ-Line Mutation Theoretical Models Biopsy standards secondary utilization Disease Management drug therapy Second Primary Neoplasms Neoplasm Staging Endometrial Neoplasms therapeutic use Medical Oncology Family Cognitive Appraisal Uncertainty control Syndromes prevention & control Genetics Risk Reduction Behavior Anxiety Electronic Health Records Psychological Assessment Attitude of Health Personnel prevention & Precision Medicine Radiosurgery Risk Patient Compliance Interviews as Topic Promotion & Maintenance of Health & Wellness [3365]
Last updated on Friday, January 03, 2020